Browse Related Topics For:

Generic Drugs The United States Food and Drug Administration

65
Pharmaceutical
61
Pharmaceutical Manufacturers
48
Prescription Drugs
40
Patents
39
Pharmaceutical Patents
35
ANDA
30
Hatch-Waxman
23
Patent Infringement
21
Patent Litigation
21
SCOTUS
20
Drug Manufacturers
15
Biosimilars
14
FDCA
14
Labeling
14
Preemption
11
Medical Devices
8
BPCIA
8
Failure To Warn
8
Healthcare
8
Reverse Payment Settlement Agreements
8
Warning Labels
7
Antitrust Litigation
7
Appeals
6
Orphan Drugs
6
Sandoz
6
Teva Pharmaceuticals
5
Affordable Care Act
5
Design Defects
5
FDA Approval
5
FTC
5
FTC v Actavis
5
Manufacturers
5
Mylan Pharmaceuticals
5
Otsuka Pharmaceutical
5
PLIVA v Mensing
5
Popular
5
Product Hopping
4
Amgen
4
Medicaid
4
Mutual Pharmaceuticals v Bartlett
4
Orange Book
3
Apotex
3
Biologics Price Competition and Innovation Act of 2009
3
Classen Immunotherapies
3
Corporate Counsel
3
GDUFA
3
Healthcare Reform
3
Medicare
3
OIG
3
Pharmacies
3
Safe Harbors
3
Sandoz v Amgen
3
Summary Judgment
3
Trademarks
3
USPTO
3
Watson Pharmaceuticals
2
Actavis Inc.
2
Amarin
2
Antitrust Provisions
2
AstraZeneca
2
Biologics
2
Brand
2
Chevron Deference
2
China
2
Citizen Petitions
2
Class Action
2
Clinical Trials
2
Commercial Marketing
2
DaimlerAG
2
Declaratory Judgments
2
Durable Medical Equipment
2
Duty to Deal
2
Elan Pharmaceuticals
2
Exclusivity
2
Food Safety
2
Foreign Manufacturers
2
GlaxoSmithKline
2
HHS
2
Inter Partes Review Proceedings
2
INTERPOL
2
Life Sciences
2
Mensing
2
New Guidance
2
NIH
2
On-Sale Bar
2
Patent Applications
2
Preliminary Injunctions
2
Prior Art
2
Product Exclusivity
2
Professional Conferences
2
Proposed Legislation
2
Proposed Regulation
2
Rule-of-Reason Analysis
2
Sherman Act
2
TRO
2
Unfair Competition
2
Websites
1
21st Century Cures Initiative
1
Abbott Laboratories
1
AbbVie
1
aBLA
1
ACOs
1
Advance Notice
1
Allergan Inc
1
Amended Complaints
1
America Invents Act
1
Antitrust Injuries
1
Approval
1
Australia
1
Best Practices
1
Biogen Idec
1
Biopharmaceutical
1
Biotechnology
1
Bipolar Disorder
1
Boehringer
1
Books
1
BPCI
1
Burden of Proof
1
CA Supreme Court
1
Canada
1
Cartwright Act
1
Carve Out Provisions
1
CDC
1
Cipro
1
Civil Monetary Penalty
1
Claim Construction
1
Clearance
1
CMS
1
Competition
1
Compliance
1
Contraceptive Coverage Mandate
1
Copyright
1
Copyright Infringement
1
Corrective Actions
1
Cost-Sharing
1
Counterfeit Drugs
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Daiichi Sankyo
1
DaimlerChrysler v Bauman
1
Defect
1
DHS
1
Diagnostic Tests
1
Dietary Supplements
1
Disclosure
1
DOHA
1
DOJ
1
DQSA
1
Draft Guidance
1
Drug Compounding
1
Drug Pricing
1
Drug Safety
1
DSCSA
1
EAR
1
EHR
1
Email
1
Enforcement
1
Enforcement Actions
1
EU
1
Exceptional Case
1
Exports
1
False Advertising
1
False Claims Act
1
FDA Warning Letters
1
FDASIA
1
Federal Question Jurisdiction
1
Federal Rule 12(b)(6)
1
Final Rules
1
First Amendment
1
First Sale Doctrine
1
Food Labeling
1
Food Recalls
1
Foreign Corporations
1
Free Speech
1
Generic
1
Gilead Sciences
1
Goodyear
1
Government Investigations
1
Grable Factors
1
Health Information Technologies
1
Highmark v. Allcare
1
Hoffman LaRoche
1
Hospitals
1
Imports
1
Information Reports
1
Informed Consent
1
Inspections
1
Intellectual Property Litigation
1
International Treaties
1
IRF Claim Processing
1
Jurisdiction
1
Justiciable Controversy
1
Kickbacks
1
Legislative Agendas
1
License Agreements
1
Licenses
1
Licensing Rules
1
Manufacturing Defects
1
Medicare Part D
1
MedPAC
1
Medtronic
1
Medtronics
1
Merck
1
Misrepresentation
1
Monopolization
1
Mootness
1
New Regulations
1
Nike
1
Non-Grandfathered Health Plans
1
Notifications
1
Novartis
1
Nursing Homes
1
Nutritional Supplements
1
Octane Fitness v. ICON
1
Off-Label Promotion
1
Out-of-State Companies
1
OxyContin
1
Patent Dance
1
Patent Invalidity
1
Patent Term Extensions
1
Patent Trial and Appeal Board
1
Patent-in-Suit
1
Pay-For-Delay
1
Personal Jurisdiction
1
PHRMA
1
Post-Grant Review
1
Premarket Approval Applications
1
Prescription Drug Plans
1
Product Labels
1
Public Meetings
1
Public Performance Rights
1
Putative Class Actions
1
Qui Tam
1
Rebates
1
Recordkeeping Requirements
1
Registration Requirement
1
REMS
1
Restraining Orders
1
Reversal
1
Reverse Payments
1
Risk Management
1
Rulemaking Process
1
Settlement
1
SNDAs
1
Spectrum
1
Standard of Review
1
Standing
1
Supply Chain
1
Takeda Pharmaceuticals
1
Tax Credits
1
Trade Secrets
1
Trademark Searches
1
Transfer of Venue
1
Vaccinations
1
Veterinary Products
1
Whistleblowers
1
WIPO
1
Women's Preventable Healthcare Mandates
1
Work Plans
1
WTO
1
Wyeth